Email: [email protected], [email protected]

Qualifications

2007 PhD studies at the Department of Medicine, University of Tartu, Estonia

2000 Undergraduate studies at the Department of Medicine, University of Tartu, Estonia

Publications (Selected)

1. Pervjakova, N., Moen, G. H., Borges, M. C., Ferreira, T., Cook, J. P., Allard, C., ... & Mägi, R. (2022). Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Human Molecular Genetics, 31(19), 3377-3391.
2. Tagoma, A., Haller‐Kikkatalo, K., Oras, A., Roos, K., Kirss, A., & Uibo, R. (2022). Plasma cytokines during pregnancy provide insight into the risk of diabetes in the gestational diabetes risk group. Journal of Diabetes Investigation, 13(9), 1596-1606.
3. Pervjakova, N., Moen, G. H., Borges, M. C., Ferreira, T., Cook, J. P., Allard, C., ... & Mägi, R. (2022). Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Human Molecular Genetics, 31(19), 3377-3391.
4. Tagoma, A., Haller‐Kikkatalo, K., Roos, K., Oras, A., Kirss, A., Ilonen, J., & Uibo, R. (2019). Interleukin‐7, T helper 1, and regulatory T‐cell activity‐related cytokines are increased during the second trimester of healthy pregnancy compared to non‐pregnant women. American Journal of Reproductive Immunology, 82(6), e13188.
5. Orro, E., Alnek, K., Reimand, T., Reimand, K., Uibo, O., Talvik, T., ... & Uibo, R. (2019). Patients with down syndrome have increased prevalence of rheumatoid factor but not autoantibodies to anti-cyclic citrullinated peptide. Clinica Chimica Acta, 495, 40-42.
6. Tagoma, A., Alnek, K., Kirss, A., Uibo, R., & Haller-Kikkatalo, K. (2018). MicroRNA profiling of second trimester maternal plasma shows upregulation of miR-195-5p in patients with gestational diabetes. Gene, 672, 137-142.
7. Haller-Kikkatalo, K., Alnek, K., Metspalu, A., Mihailov, E., Metsküla, K., Kisand, K., ... & Uibo, R. (2017). Demographic associations for autoantibodies in disease-free individuals of a European population. Scientific Reports, 7(1), 44846.
8. Tšuiko, O., Nõukas, M., Žilina, O., Hensen, K., Tapanainen, J. S., Mägi, R., ... & Kurg, A. (2016). Copy number variation analysis detects novel candidate genes involved in follicular growth and oocyte maturation in a cohort of premature ovarian failure cases. Human reproduction, 31(8), 1913-1925.
9. Haller-Kikkatalo, K., & Uibo, R. (2016). Clinical recommendations for the use of islet cell autoantibodies to distinguish autoimmune and non-autoimmune gestational diabetes. Clinical reviews in allergy & immunology, 50(1), 23-33.
10. Haller-Kikkatalo, K., Uibo, R., Kurg, A., & Salumets, A. (2015). The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry-based study. Human reproduction, 30(5), 1229-1238.
11. Haller‐Kikkatalo, K., Pruul, K., Kisand, K., Nemvalts, V., Reimand, K., & Uibo, R. (2015). GADA and anti‐ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults. European Journal of Clinical Investigation, 45(3), 255-262.
12. Metsalu, T., Viltrop, T., Tiirats, A., Rajashekar, B., Reimann, E., Kõks, S., ... & Salumets, A. (2014). Using RNA sequencing for identifying gene imprinting and random monoallelic expression in human placenta. Epigenetics, 9(10), 1397-1409.

Profile Details

https://www.etis.ee/CV/Kadri_Haller-Kikkatalo

https://scholar.google.com.hk/citations?hl=zh-CN&user=u-2mxccAAAAJ